Table 2.
CRPC-free and overall survival in each study.
| CRPC-free survival | Low volume | High volume | OS | Low volume | High volume |
| CHAARTED | 31.0/22.7 | 14.9/8.6 | CHAARTED | NR/NR | 49.2/32.2 |
| CHAARTED (all patients) | 20.2/11.7 | CHAARTED (all patients) | 57.6/44.0 | ||
| Our cohort | 56.9 | 12.5 | Our cohort | 95.1 | 50.1 |
|
| |||||
| CRPC-free survival | Low risk | High risk | OS | Low risk | High risk |
| LATITUDE | — | 33.2/7.4 | LATITUDE | — | 53.3/36.5 |
| LATITUDE (Japanese cohort) | — | NR/9.3 | LATITUDE (Japanese cohort) | — | NR/NR |
| Our cohort | 37.3 | 13.6 | Our cohort | 92.7 | 54.0 |